Annette W.G. van der Velden

Author

Also Known As

A W G van der Velden, A.W.G. van der Velden, Annette W G van der Velden, Annette W. G. van der Velden, Annette W.G. van der Velden, Annette WG van der Velden

Publications

727

Citations

H-Index

Concepts

All Affiliations

Martini Ziekenhuis Radboud University Nijmegen University Medical Center Groningen University of Groningen Medisch Centrum Alkmaar

About

Annette W.G. van der Velden is an author at Martini Ziekenhuis specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	224
2	Immunology	2	2	108
3	Health Sciences	1	1	36
4	Psychiatry	1	1	80
5	Psychology	1	1	80

Annette W.G. van der Velden

Publications

697

Citations

H-Index

Page 1

	Year	Citations
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer Annelies H. Boekhout, Jourik A. Gietema, Bojana Milojkovic Kerklaan, JAMA Oncology	2016	189
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma Sonja Zweegman, Bronno van der Holt, Ulf‐Henrik Mellqvist, Blood	2016	111
Web-Based Tailored Psychoeducation for Breast Cancer Patients at the Onset of the Survivorship Phase: A Multicenter Randomized Controlled Trial J. M. Admiraal, Annette W.G. van der Velden, J. Geerling, Journal of Pain and Symptom Management Cancer LiteracyPsychiatryBreast Cancer PatientsMedicineSurvivorship Phase	2017	80
Response to influenza virus vaccination during chemotherapy in patients with breast cancer A. Meerveld-Eggink, Okke de Weerdt, Ankie M.T. van der Velden, Annals of Oncology VaccinationVaccine SafetyImmunologyVirus VaccinationBreast Cancer	2011	60
Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumours M.L. Wumkes, Ankie M.T. van der Velden, Maartje Los, Vaccine VaccinationSerum Antibody ResponseImmunologyVirus VaccinationSolid Tumours	2013	48
Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness Gabriela G.F. van der Schoot, Harm L. Ormel, Nico-Derk L. Westerink, JACC CardioOncology	2022	48
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study Anna van der Voort, Fleur M. Louis, Mette S. van Ramshorst, The Lancet Oncology Neoadjuvant Chemotherapy DurationBreast OncologyMedical ImagingMedicineMri-guided Optimisation	2024	36
Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial Rowan Kuiper, Sonja Zweegman, Mark van Duin, Blood Advances	2020	33
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial S.B. Vliek, Iris Noordhoek, Elma Meershoek‐Klein Kranenbarg, Journal of Clinical Oncology	2022	19
Feasibility of hospital-initiated non-facilitator assisted advance care planning documentation for patients with palliative care needs Maaike Kok, Gertruud F. M. van der Werff, J. Geerling, BMC Palliative Care	2018	17

Page 1